America in Transition Pages

Tuesday, March 8, 2016

FDA Concedes Defeat on Off-Label Drug Marketing

(MedPage Today) -- Amarin can market its fish-oil product (Vascepa) for unapproved indications

from MedPage Today Washington Watch http://ift.tt/1LPShQf
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)